Nick Lane



On Primo Levi and the art of science writing

On pH and why it's good to score 7.4

Vampires and porphyria

The Observer - Review of Creation by Adam Rutherford


FEATURES FOR EUROTIMES (European Society for Cataract and Refractive Surgery)

1. Lane N. Darwin and the evolution of the eye. EuroTimes (ESCRS) June 2009.

2. Lane N. MRSA: The rising menace. EuroTimes (ESCRS) October 2008.

3. Lane N. Who is paying the piper? Open access journals. EuroTimes (ESCRS) January 2008.

4. Lane N. Beyond the IOL. EuroTimes (ESCRS) September 2007.

5. Lane N. To block or not to block: Is blue light the enemy? EuroTimes (ESCRS) July 2007.

6. Lane N. Cannabis and glaucoma - the inside story. EuroTimes (ESCRS) April 2007.

7. Lane N. The great accomodation debate. EuroTimes (ESCRS) January 2007.

8. Lane N. Mitochondria – alpha and omega of retinal disease? EuroTimes (ESCRS) September 2006.

9. Lane N. Pioneers past and present; but where are the boundaries of the justifiable? EuroTimes (ESCRS) January 2006.

10. Lane N. New VEGF antagonists in AMD: new quandaries abound. EuroTimes (ESCRS) November 2005.

11. Lane N. Stem cells in ophthalmology: dawn of a new era? EuroTimes (ESCRS) October 2005.

12. Lane N. Ophthalmic gene testing: ready for prime time? EuroTimes (ESCRS) August 2005.

13. Lane N. Conflict of interest crisis: researchers and regulators at odds over reform proposals. EuroTimes (ESCRS) June 2005.

14. Lane N. Evidence-based medicine – never better than the evidence itself. EuroTimes (ESCRS) June 2004.

15. Lane N. Rheopheresis: ready for prime time? EuroTimes (ESCRS) November 2004.

16. Lane N. Vision 2020: Eliminating preventable blindness in the developing world? EuroTimes (ESCRS) February 2004.

17. Lane N. EMEA on the brink of the new EU. EuroTimes (ESCRS) November 2003.

18. Lane N. Antioxidants: who do you believe? EuroTimes (ESCRS) October 2003.

19. Lane N. Verteporfin’s efficacy in AMD comes into focus. EuroTimes (ESCRS) August 2003.